David Weill - Aug 29, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Director
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Aug 29, 2023
Transactions value $: $155,000
Form type: 4
Date filed: 8/30/2023, 04:33 PM
Previous filing: May 30, 2023
Next filing: May 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Purchase	$155K	+2.5K	+22.34%	$62.00	13.7K	Aug 29, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $61.98 to $62.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2	Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $61.98 to $62.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.